TY - JOUR
T1 - Neonatal mouse gut metabolites influence cryptosporidium parvum infection in intestinal epithelial cells
AU - Vandussen, Kelli L.
AU - Funkhouser-Jones, Lisa J.
AU - Akey, Marianna E.
AU - Schaefer, Deborah A.
AU - Ackman, Kevin
AU - Riggs, Michael W.
AU - Stappenbeck, Thaddeus S.
AU - David Sibley, L.
N1 - Funding Information:
We thank the Genome Technology Access Center (GTAC) in the Department of Genetics at Washington University School of Medicine for help with 16S rRNA sequencing and analysis. The GTAC is partially supported by NCI Cancer Center support grant number P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA grant number UL1TR002345 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.
Funding Information:
Support was provided in part by grants from the NIH (AI 145496 to L.D.S.) and USDA NIFA project number ARZT-5704210-A50-133. K.L.V. was supported by NIH grant DK109081.
Funding Information:
We are grateful to William Witola, University of Illinois at Urbana-Champaign, for providing the C. parvum oocysts used here; Megan Baldridge for helpful advice; and Soumya Ravindran for cell culture support. Support was provided in part by grants from the NIH (AI 145496 to L.D.S.) and USDA NIFA project number ARZT-5704210-A50-133. K.L.V. was supported by NIH grant DK109081. We thank the Genome Technology Access Center (GTAC) in the Department of Genetics at Washington University School of Medicine for help with 16S rRNA sequencing and analysis. The GTAC is partially supported by NCI Cancer Center support grant number P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA grant number UL1TR002345 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.
Publisher Copyright:
© 2020 VanDussen et al.
PY - 2020/11/1
Y1 - 2020/11/1
N2 - The protozoan parasite Cryptosporidium sp. is a leading cause of diarrheal disease in those with compromised or underdeveloped immune systems, par-ticularly infants and toddlers in resource-poor localities. As an enteric pathogen, Cryptosporidium sp. invades the apical surface of intestinal epithelial cells, where it resides in close proximity to metabolites in the intestinal lumen. However, the effect of gut metabolites on susceptibility to Cryptosporidium infection remains largely unstudied. Here, we first identified which gut metabolites are prevalent in neonatal mice when they are most susceptible to Cryptosporidium parvum infection and then tested the isolated effects of these metabolites on C. parvum invasion and growth in intestinal epithelial cells. Our findings demonstrate that medium or long-chain satu-rated fatty acids inhibit C. parvum growth, perhaps by negatively affecting the stream-lined metabolism in C. parvum, which is unable to synthesize fatty acids. Conversely, long-chain unsaturated fatty acids enhanced C. parvum invasion, possibly by modulat-ing membrane fluidity. Hence, gut metabolites, either from diet or produced by the microbiota, influence C. parvum growth in vitro and may also contribute to the early susceptibility to cryptosporidiosis seen in young animals.
AB - The protozoan parasite Cryptosporidium sp. is a leading cause of diarrheal disease in those with compromised or underdeveloped immune systems, par-ticularly infants and toddlers in resource-poor localities. As an enteric pathogen, Cryptosporidium sp. invades the apical surface of intestinal epithelial cells, where it resides in close proximity to metabolites in the intestinal lumen. However, the effect of gut metabolites on susceptibility to Cryptosporidium infection remains largely unstudied. Here, we first identified which gut metabolites are prevalent in neonatal mice when they are most susceptible to Cryptosporidium parvum infection and then tested the isolated effects of these metabolites on C. parvum invasion and growth in intestinal epithelial cells. Our findings demonstrate that medium or long-chain satu-rated fatty acids inhibit C. parvum growth, perhaps by negatively affecting the stream-lined metabolism in C. parvum, which is unable to synthesize fatty acids. Conversely, long-chain unsaturated fatty acids enhanced C. parvum invasion, possibly by modulat-ing membrane fluidity. Hence, gut metabolites, either from diet or produced by the microbiota, influence C. parvum growth in vitro and may also contribute to the early susceptibility to cryptosporidiosis seen in young animals.
KW - 16S rRNA
KW - Cryptosporidium parvum
KW - Enteric infection
KW - Essential nutrient
KW - Fatty acid
KW - Metabolite
KW - Microbiota
UR - http://www.scopus.com/inward/record.url?scp=85098533318&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098533318&partnerID=8YFLogxK
U2 - 10.1128/MBIO.02582-20
DO - 10.1128/MBIO.02582-20
M3 - Article
C2 - 33323514
AN - SCOPUS:85098533318
SN - 2161-2129
VL - 11
SP - 1
EP - 16
JO - mBio
JF - mBio
IS - 6
M1 - e02582-20
ER -